Ignite Creation Date:
2025-12-25 @ 2:43 AM
Ignite Modification Date:
2025-12-27 @ 11:34 PM
Study NCT ID:
NCT01947933
Status:
COMPLETED
Last Update Posted:
2024-07-25
First Post:
2013-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Safety Study of Mirikizumab (LY3074828)
Sponsor:
Eli Lilly and Company
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-10
Start Date Type:
None
Primary Completion Date:
2015-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2015-02
Completion Date Type:
ACTUAL
First Submit Date:
2013-09-18
First Submit QC Date:
None
Study First Post Date:
2013-09-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2023-05-05
Results First Submit QC Date:
None
Results First Post Date:
2024-07-25
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-16
Last Update Post Date:
2024-07-25
Last Update Post Date Type:
ACTUAL